- Home
- MTW vs AUTL Comparison
MTW vs AUTL Comparison
Compare MTW & AUTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MTW | AUTL |
|---|---|---|
| Founded | 1902 | 2014 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Construction/Ag Equipment/Trucks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 479.6M | 433.8M |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | MTW | AUTL |
|---|---|---|
| Price | $13.54 | $1.39 |
| Analyst Decision | Sell | Strong Buy |
| Analyst Count | 4 | 3 |
| Target Price | ★ $10.25 | $8.33 |
| AVG Volume (30 Days) | 220.6K | ★ 2.7M |
| Earning Date | 02-11-2026 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 1.58 | N/A |
| Revenue | ★ $2,159,800,000.00 | $51,128,000.00 |
| Revenue This Year | $0.28 | $672.42 |
| Revenue Next Year | $6.14 | $84.48 |
| P/E Ratio | $8.58 | ★ N/A |
| Revenue Growth | N/A | ★ 406.67 |
| 52 Week Low | $7.06 | $1.11 |
| 52 Week High | $14.33 | $2.70 |
Technical Indicators
Market Signals| Indicator | MTW | AUTL |
|---|---|---|
| Relative Strength Index (RSI) | 60.01 | 37.52 |
| Support Level | $13.69 | $1.34 |
| Resistance Level | $14.33 | $1.97 |
| Average True Range (ATR) | 0.47 | 0.15 |
| MACD | 0.05 | -0.07 |
| Stochastic Oscillator | 67.38 | 5.48 |
Price Performance
Historical ComparisonAbout MTW Manitowoc Company Inc. (The)
Manitowoc Co Inc provides engineered lifting solutions. It designs and manufactures mobile telescopic cranes, tower cranes, lattice-boom crawler cranes, and boom trucks. It offers products under brand names such as Grove, Manitowoc, National Crane, Potain, Shuttlelift, and Manitowoc Crane Care. Its crane products serve dealers, rental companies, contractors, and government entities in diverse markets, including energy production/distribution and utility, petrochemical and industrial, infrastructure, and commercial/residential construction. Manitowoc has three reportable segments: the Americas, Europe and Africa, and the Middle East and Asia-Pacific. The Americas segment generates the majority of the revenue for the company.
About AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.